Peripheral Artery Disease in Thromboinflammation Era: Pathophysiological, Clinical and Therapeutic Implications
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 851
Special Issue Editors
Interests: peripheral artery disease; neurosonology; atherosclerosis; transcranial doppler; cerebral hemodynamic
Special Issues, Collections and Topics in MDPI journals
Interests: ischemic stroke in diabetes; diabetic foot; Anderson-Fabry disease; cytokines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Peripheral artery disease (PAD) is a significant and growing global health concern, affecting millions of individuals and contributing to severe morbidity and mortality. Over the years, research has expanded our understanding of PAD, revealing its complex interplay with thromboinflammatory mechanisms. The emergence of novel diagnostic tools and therapeutic interventions has further shaped the landscape of PAD management, necessitating a dedicated exploration of these developments in the thromboinflammation era.
This Special Issue aims to provide a comprehensive overview of recent advancements in PAD research, with a particular focus on its pathophysiological, clinical, and therapeutic implications in the context of thromboinflammation. By integrating multidisciplinary perspectives, this issue will serve as a platform to highlight innovative research, identify gaps in current knowledge, and propose future directions for improved patient outcomes.
Recent studies have underscored the pivotal role of thromboinflammatory processes in PAD progression and complications. Advances in molecular biology, imaging techniques, and targeted therapies have paved the way for a more refined understanding of disease mechanisms. This Special Issue will feature pioneering research that explores novel biomarkers, mechanistic insights, and interventional strategies, aiming to bridge the gap between basic science and clinical application.
We welcome high-quality contributions that present original research, comprehensive reviews, and insightful perspectives on PAD in the thromboinflammation era. Submissions should demonstrate rigorous scientific inquiry and offer significant contributions to the field. Topics of interest include, but are not limited to, the following:
- Pathophysiological mechanisms linking thromboinflammation and PAD;
- Novel diagnostic biomarkers and imaging advancements;
- Innovative therapeutic approaches, including pharmacological and interventional strategies;
- Clinical management and patient outcomes in the context of thromboinflammation.
We particularly encourage interdisciplinary studies that integrate cardiovascular, immunological, and molecular research to foster new therapeutic insights. All submissions will undergo a rigorous peer-review process to ensure the highest standards of scientific integrity and impact.
We look forward to receiving groundbreaking contributions that will shape the future of PAD research and contribute to the advancement of knowledge in this evolving field.
Dr. Giuseppe Miceli
Prof. Dr. Antonino Tuttolomondo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thromboinflammation
- peripheral artery disease
- atherosclerosis
- acute limb ischemia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
